Bioventix (BVXP)

Sector:

Pharma and Biotech

Index:

FTSE AIM 100

4,411.54p
   
  • Change Today:
    -13.46p
  • 52 Week High: 5,060.00
  • 52 Week Low: 3,500.00
  • Currency: UK Pounds
  • Shares Issued: 5.22m
  • Volume: 0
  • Market Cap: £230.27m

Bioventix Overview

Bioventix was founded in 2003 as a biotechnology company specialising in the creation and supply of high-affinity sheep monoclonal antibodies (SMAs) for use in immunodiagnostics. However, the antibody technology laboratory and some of the staff have been based at the same location in Farnham, Surrey, UK since the early 1990s.

Key Personnel

CEO: Peter John Harrison
CFO: Bruce Hiscock
Chairman: Ian James Nicholson
Independent Non-Executive Director: Nicholas (Nick) John McCooke
Independent Non-Executive Director: Joanne (Jo) Pisani
Non-Executive Dir:

Contact Details

Address: 27-28 Eastcastle Street, London, United Kingdom, W1W 8DH
Website: http://www.bioventix.com

Listings

Sector: Pharma and Biotech(LSE)
Index: FTSE AIM All-Share, FTSE AIM 100
ISIN: GB00B4QVDF07

Note 1: Prices and trades are provided by Digital Look Corporate Solutions and are delayed by at least 15 minutes.

 

Bioventix Market Data

Currency UK Pounds
Share Price 4,411.54p
Change Today -13.46p
% Change -0.30 %
52 Week High 5,060.00
52 Week Low 3,500.00
Volume 0
Shares Issued 5.22m
Market Cap £230.27m

Bioventix Star Ratings

Compare performance with the sector and the market.
more star ratings
Key: vs Market vs Sector
Value
98.29% below the market average98.29% below the market average98.29% below the market average98.29% below the market average98.29% below the market average
100% below the sector average100% below the sector average100% below the sector average100% below the sector average100% below the sector average
Price Trend
74.99% above the market average74.99% above the market average74.99% above the market average74.99% above the market average74.99% above the market average
92.98% above the sector average92.98% above the sector average92.98% above the sector average92.98% above the sector average92.98% above the sector average
Income
30.41% below the market average30.41% below the market average30.41% below the market average30.41% below the market average30.41% below the market average
Sector averageSector averageSector averageSector averageSector average
Growth
34.51% below the market average34.51% below the market average34.51% below the market average34.51% below the market average34.51% below the market average
29.73% above the sector average29.73% above the sector average29.73% above the sector average29.73% above the sector average29.73% above the sector average

Bioventix Dividends

  Latest Previous
  1st Interim 2nd Interim
Ex-Div 11-Apr-24 09-Nov-23
Paid 26-Apr-24 24-Nov-23
Amount 68.00p 90.00p

Trades for --2024

Time Volume / Share Price
0 @ 0.000p

Bioventix Key Personnel

CEO Peter John Harrison
Chair Ian James Nicholson
CFO Bruce Hiscock

Top of Page